1. Aloj L, Lang L, Jagoda E, Neumann RD, Eckelman WC (1996) Evaluation of human transferrin radiolabeled with N-succinimidyl 4-[fluorine-18](fluoromethyl) benzoate. J Nucl Med 37:1408–1412
2. Beer AJ, Haubner R, Goebel M, Luderschmidt S, Spilker ME, Wester HJ, Weber WA, Schwaiger M (2005) Biodistribution and pharmacokinetics of the avb3-selective tracer 18F-galacto-RGD in cancer patients. J Nucl Med 46:1333–1341
3. Bergmann R, Scheunemann M, Heichert C, Mading P, Wittrisch H, Kretzschmar M, Rodig H, Tourwe D, Iterbeke K, Chavatte K, Zips D, Reubi JC, Johannsen B (2002) Biodistribution and catabolism of 18F-labelled neurotensin (8–13) analogs. Nucl Med Biol 29:61–72
4. Block D, Coenen HH, Stöcklin G. (1988) N.c.a. 18F-fluoroacylation via fluorocarboxylic acid esters. J Lab Compd Radiopharm 25:185
5. Bock, M., Haubner, R., Senekowitsch-Schmidtke, R., Kessler, H., Stöcklin, G., Schwaiger, M., Wester, H.J (1999) Homo-and heteromultimeric ligand systems as tracers for tumorimaging und endoradiotherapy. Nuclear Med 38:A44 (abstract)